trending Market Intelligence /marketintelligence/en/news-insights/trending/rPKzYflrUX4_yh7oFOQecw2 content esgSubNav
In This List

Intellia Therapeutics appoints president/CEO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Intellia Therapeutics appoints president/CEO

John Leonard will become Intellia Therapeutics Inc.'s president and CEO on Jan. 1, 2018.

Leonard succeeds Nessan Bermingham, the company's founding president and CEO.

Leonard was most recently the executive vice president of research and development at the genome editing company.